Senior investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in go-to-market strategy, corporate development and board-level governance.
Sarah H. Schmidt brings extensive experience leading cross-functional teams at venture-backed startups and in corporate M&A, advising founders on scaling revenue and capital strategies. Known for sector-driven deal sourcing, portfolio value creation and hands-on operational support to management teams.
Senior investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in go-to-market strategy, corporate development and board-level governance.
Sarah H. Schmidt brings extensive experience leading cross-functional teams at venture-backed startups and in corporate M&A, advising founders on scaling revenue and capital strategies. Known for sector-driven deal sourcing, portfolio value creation and hands-on operational support to management teams.
Growth-oriented investor leveraging operating leadership to back revenue-stage technology and healthcare companies, prioritizing deal flow from sector networks and founder-led teams. Focuses on pragmatic go-to-market and corporate development plays, allocating capital to scalable revenue models with clear path to enterprise adoption. Balances active board-level governance and hands-on operational support with measured capital pacing, emphasizing unit economics, customer retention, and exit optionality over headline valuations.
Growth-oriented investor leveraging operating leadership to back revenue-stage technology and healthcare companies, prioritizing deal flow from sector networks and founder-led teams. Focuses on pragmatic go-to-market and corporate development plays, allocating capital to scalable revenue models with clear path to enterprise adoption. Balances active board-level governance and hands-on operational support with measured capital pacing, emphasizing unit economics, customer retention, and exit optionality over headline valuations.
| Trades 1075 | Longs Won 496/1075 46% | Profit Factor 8.85 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $718,451.08 |
| Average Win $251,275.4 | Best Trade (Jul 13) $16.87M | Sharpe Ratio -10.2 |
| Average Loss -$24,312.93 | Worst Trade (Dec 31) -$3.35M | Z-Score -0.48 (36.78%) |
| Commissions $0 | Avg. Trade Length 4m 2w | Expectancy $102,842.24 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 43,478 | 39,130 | 34,783 | 30,435 | 26,087 | 21,739 | 17,391 | 13,043 | 8,696 | 4,348 |